PURPOSE OF REVIEW: In this manuscript, the recent advancements and novel approaches for regeneration of the ocular surface are summarized. RECENT FINDINGS: Following severe injuries, persistent inflammation can alter the rehabilitative capability of the ocular surface environment. Limbal stem cell deficiency (LSCD) is one of the most characterized ocular surface disorders mediated by deficiency and/or dysfunction of the limbal epithelial stem cells (LESCs) located in the limbal niche. Currently, the most advanced approach for revitalizing the ocular surface and limbal niche is based on transplantation of limbal tissues harboring LESCs. Emerging approaches have focused on restoring the ocular surface microenvironment using (1) cell-based therapies including cells with capabilities to support the LESCs and modulate the inflammation, e.g., mesenchymal stem cells (MSCs), (2) bio-active extracellular matrices from decellularized tissues, and/or purified/synthetic molecules to regenerate the microenvironment structure, and (3) soluble cytokine/growth factor cocktails to revive the signaling pathways. SUMMARY: Ocular surface/limbal environment revitalization provide promising approaches for regeneration of the ocular surface.
PURPOSE OF REVIEW: In this manuscript, the recent advancements and novel approaches for regeneration of the ocular surface are summarized. RECENT FINDINGS: Following severe injuries, persistent inflammation can alter the rehabilitative capability of the ocular surface environment. Limbal stem cell deficiency (LSCD) is one of the most characterized ocular surface disorders mediated by deficiency and/or dysfunction of the limbal epithelial stem cells (LESCs) located in the limbal niche. Currently, the most advanced approach for revitalizing the ocular surface and limbal niche is based on transplantation of limbal tissues harboring LESCs. Emerging approaches have focused on restoring the ocular surface microenvironment using (1) cell-based therapies including cells with capabilities to support the LESCs and modulate the inflammation, e.g., mesenchymal stem cells (MSCs), (2) bio-active extracellular matrices from decellularized tissues, and/or purified/synthetic molecules to regenerate the microenvironment structure, and (3) soluble cytokine/growth factor cocktails to revive the signaling pathways. SUMMARY: Ocular surface/limbal environment revitalization provide promising approaches for regeneration of the ocular surface.
Authors: Maria Notara; Alex J Shortt; Grazyna Galatowicz; Virginia Calder; Julie T Daniels Journal: Stem Cell Res Date: 2010-08-03 Impact factor: 2.020
Authors: Maryam A Shafiq; Richard A Gemeinhart; Beatrice Y J T Yue; Ali R Djalilian Journal: Tissue Eng Part C Methods Date: 2011-12-22 Impact factor: 3.056
Authors: Laura J Bray; Karina A George; Dietmar W Hutmacher; Traian V Chirila; Damien G Harkin Journal: Biomaterials Date: 2012-02-13 Impact factor: 12.479
Authors: Hong Qi; De-Quan Li; H David Shine; Zhuo Chen; Kyung-Chul Yoon; Dan B Jones; Stephen C Pflugfelder Journal: Exp Eye Res Date: 2007-09-15 Impact factor: 3.467
Authors: Joo Youn Oh; Mee Kum Kim; Hyun Ju Lee; Jung Hwa Ko; Won Ryang Wee; Jin Hak Lee Journal: Vet Ophthalmol Date: 2009 Nov-Dec Impact factor: 1.644
Authors: Sohil Amin; Elmira Jalilian; Eitan Katz; Charlie Frank; Ghasem Yazdanpanah; Victor H Guaiquil; Mark I Rosenblatt; Ali R Djalilian Journal: Vision (Basel) Date: 2021-09-22